Muxiang Zhou MD
- Department of Pediatrics
Professor
- (404) 727-1426
- mzhou@emory.edu
- Zhou Laboratory
-
Aflac Cancer and Blood Disorders Center
Pediatrics
1760 Haygood Drive
Academic Appointment
- Professor of Pediatrics, Emory University
Education
Degrees
- MD from Tongji Medical University
Research
Focus
- The major focus of research has been the molecular analysis and identification of signaling pathways that confer cancer promotion and development of anticancer resistance, which aims to exploit innovative approach and novel drugs for targeting cancer therapeutics.
Publications
-
An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues.
Cancer Lett Volume: 598 Page(s): 217126
08/28/2024 Authors: Liu T; Gu L; Mui A; Wu Z; Albadari N; Li W; Zhou M -
Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold.
Eur J Med Chem Volume: 255 Page(s): 115423
07/05/2023 Authors: Albadari N; Xie Y; Liu T; Wang R; Gu L; Zhou M; Wu Z; Li W -
MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma.
Front Oncol Volume: 12 Page(s): 1058726
01/01/2022 Authors: Liu T; Gu L; Wu Z; Albadari N; Li W; Zhou M -
Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor.
J Med Chem Volume: 64 Page(s): 1930 - 1950
02/25/2021 Authors: Wu Z; Gu L; Zhang S; Liu T; Lukka PB; Meibohm B; Bollinger JC; Zhou M; Li W -
Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogs.
Bioorg Med Chem Volume: 27 Page(s): 3860 - 3865
09/01/2019 Authors: Draganov AB; Yang X; Anifowose A; De La Cruz LKC; Dai C; Ni N; Chen W; De Los Santos Z; Gu L; Zhou M -
Mutual regulation of MDM4 and TOP2A in cancer cell proliferation
Volume: 79
07/01/2019 Authors: Liu T; Zhang H; Yi S; Gu L; Zhou M -
Mutual regulation of MDM4 and TOP2A in cancer cell proliferation.
Mol Oncol Volume: 13 Page(s): 1047 - 1058
05/01/2019 Authors: Liu T; Zhang H; Yi S; Gu L; Zhou M -
Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice.
Mol Cancer Ther Volume: 17 Page(s): 497 - 507
02/01/2018 Authors: Gu L; Zhang H; Liu T; Draganov A; Yi S; Wang B; Zhou M -
FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2.
Oncogene Volume: 36 Page(s): 1678 - 1686
03/23/2017 Authors: Liu T; Xiong J; Yi S; Zhang H; Zhou S; Gu L; Zhou M -
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
Nature Volume: 539 Page(s): 304 - 308
11/10/2016 Authors: Dong L; Yu W-M; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT